Because NANOG, in the form of NANOGP8 expression, is required for the maintenance of CD133+ CSC, we used CD133 antibody for the immunocapture of CSC from the mixed population of GBM cells [20]. This evidence concerns the gene NANOGP8 and glioblastoma.